Using wearable devices to assess activity and health in transgender cancer survivors
Study to Remotely Monitor Activity in Transgender Cancer Survivors
This study tests whether wearable devices can help track daily activity and health in transgender cancer survivors to see how their cancer treatment affects their physical and emotional well-being.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 20 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Cedars-Sinai Medical Center Academic / other |
| Locations | 1 site (Los Angeles, California) |
| Trial ID | NCT05391217 on ClinicalTrials.gov |
What this trial studies
This observational study evaluates the feasibility and acceptability of using wearable activity monitors to remotely assess daily activity and patient-reported outcomes among transgender cancer survivors. Participants will wear devices that track their daily steps, sleep patterns, and other activity metrics over a two-week period. The study aims to understand how cancer-related symptoms and treatment side effects impact physical function and emotional well-being. Qualitative interviews will also be conducted to explore barriers to physical activity and the relationship between cancer history, treatment, and gender-affirming hormone therapy.
Who should consider this trial
Good fit: Ideal candidates include transgender individuals aged 18 and older with a history of cancer or currently receiving cancer treatment, as well as those without a cancer history for comparison.
Not a fit: Patients who do not identify as transgender or those with certain medical implants that may interfere with wearable technology will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the health and activity levels of transgender cancer survivors, leading to improved support and interventions tailored to their needs.
How similar studies have performed: While there is limited research specifically targeting transgender cancer survivors with this approach, studies using wearable technology for remote health monitoring have shown promise in other populations.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Self-identifies as transgender person with a history of cancer or receiving treatment for cancer in the last five years from screening for the current study (case) OR self-identifies as transgender person without a history of cancer (control) * 18 years or older * Ambulatory (use of walking aids, such as cane and rollator, is acceptable) * Access to a device (e.g., smartphone, tablet, iPhone) that has the capability to sync to the Fitbit * Have an understanding, ability, and willingness to fully comply with study procedures and restrictions * Can read and understand English, Spanish, or Tagalog (for participant surveys and interviews) * Informed consent obtained from subject and ability for subject to comply with the requirements of the study. Exclusion Criteria: * Any person that does not meet the listed criteria above * Using a pacemaker, implantable cardiac defibrillator, neurostimulator, implantable hearing aids, cochlear implants, or other electronic medical equipment\*. However, removable hearing aids are permitted.
Where this trial is running
Los Angeles, California
- Cedars-Sinai Medical Center — Los Angeles, California, United States (Recruiting)
Study contacts
- Principal investigator: Gillian Gresham, PhD — Cedars-Sinai Medical Center
- Study coordinator: Gillian Gresham
- Email: gillian.gresham@cshs.org
- Phone: 310-423-3341
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.